European Sepsis Care Survey
NCT05059808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1450
Last updated 2023-06-13
Summary
The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.
Conditions
Sponsors & Collaborators
-
European Sepsis Alliance
collaborator UNKNOWN -
European Society of Anaesthesiology and Intensive Care
collaborator OTHER -
European Society for Emergency Medicine (EUSEM) Research Network
collaborator NETWORK -
European Society of Clinical Microbiology and Infectious Diseases, ESGBIES Study Group
collaborator UNKNOWN -
European Society of Intensive Care Medicine
collaborator OTHER -
Sepsisdialog, Germany
collaborator UNKNOWN -
European Shock Society
collaborator UNKNOWN -
Becton, Dickinson and Company
collaborator INDUSTRY -
University Medicine Greifswald
lead OTHER
Principal Investigators
-
Christian S Scheer · Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany
-
Adam Linder · European Sepsis Alliance
-
Daniela Filipescu · European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care
-
Evangelos Giamarellos-Bourboulis · European Sepsis Alliance, European Shock Society
-
Evgeny Idelevich · ESCMID/Study Group for Bloodstream Infections, Endocarditis and Sepsis
-
Konrad Reinhart · Global Sepsis Alliance
-
Matthias Gründling · Quality management project Sepsisdialog
-
Ricard Ferrer · European Society of Intensive Care Medicine
-
Said Laribi · European Society for Emergency Medicine (EUSEM) Research Network
-
Manu Malbrain · International Fluid Academy
-
Gabriella Bottari · European Society of Paediatric and Neonatal Intensive Care
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-01
- Primary Completion
- 2022-04-30
- Completion
- 2022-10-30
Countries
- Belgium
- Czechia
- Denmark
- Finland
- France
- Germany
- Greece
- Israel
- Italy
- Moldova
- Netherlands
- Norway
- Poland
- Portugal
- Romania
- Russia
- Spain
- Sweden
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
European Prospective Bloodstream Infection Cohort
NCT07082322 ·Status: NOT_YET_RECRUITING
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Impact of a Prehospital Sepsis Protocol on Timely Antibiotic Administration and Subsequent Adverse Events
NCT05502107 ·Status: COMPLETED ·Phase: NA
-
Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol
NCT05304728 ·Status: ENROLLING_BY_INVITATION
-
SEPSIS 3 Critera for Risk Stratification in Emergency Patients
NCT02738164 ·Status: COMPLETED
-
Sepsis Characterization in Kilimanjaro
NCT05139459 ·Status: COMPLETED
-
Comparing Prognostic Performance of SEPSIS 2 and SEPSIS 3 Strategies at the Emergency Service
NCT03355833 ·Status: COMPLETED
-
Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis
NCT03620409 ·Status: COMPLETED
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328 ·Status: UNKNOWN
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Jena Sepsis Registry
NCT02165501 ·Status: UNKNOWN
-
Evaluation of the Performance of Sepsis Predictive Scores on the Elderly Population in the Emergency Department.
NCT04721275 ·Status: UNKNOWN
-
Epirubicin for the Treatment of Sepsis & Septic Shock
NCT05033808 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating a CytoSorb Score in Septic Shock
NCT03977688 ·Status: COMPLETED
-
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
NCT04571801 ·Status: COMPLETED ·Phase: NA
-
Coagulation Disturbances in COVID-19 Septic Patients
NCT05496816 ·Status: COMPLETED
-
Hydrocortisone for Prevention of Septic Shock
NCT00670254 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Metabolic Cluster Analysis in Septic Shock Patients
NCT06500156 ·Status: RECRUITING
-
Emergency Echocardiography in Sepsis
NCT04580888 ·Status: COMPLETED ·Phase: NA
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Utility of Presepsin in Distinguishing Between Sepsis and SIRS
NCT02052895 ·Status: COMPLETED
-
Early-Onset Sepsis an NICHD/CDC Surveillance Study
NCT02410486 ·Status: COMPLETED